Quartz Crystal Microbalance Method to Measure Nanoparticle-Receptor Interactions and Evaluate Nanoparticle Design...

Area of Science:

• Nanotechnology and Biomedical Engineering
• Surface Science and Biophysics

Background:

• Active targeting of biological targets using nanoparticle-ligand bioconjugates is a key area of research.
• Evaluating the precise interactions between engineered nanoparticles (NPs) and biological receptors remains a challenge.
• A foundational understanding of bionanoparticle recognition is emerging, but practical evaluation methods are underdeveloped.

Purpose of the Study:

• To adapt the quartz crystal microbalance (QCM) technique for evaluating interactions between engineered nanoparticles and biological receptors.
• To gain concrete insights into the interactions between different NP architectures and receptor assemblies.
• To assess the impact of NP engineering parameters on construct-receptor interactions.

Main Methods:

• Adaptation of the quartz crystal microbalance (QCM) method, typically used for molecular ligand-receptor interactions.
• Utilizing a model bionanoparticle system grafted with oriented apolipoprotein E (ApoE) fragments.
• Measuring construct-receptor interactions across biologically relevant exchange times and evaluating parameters like graft density, receptor density, and linker length.

Main Results:

• The adapted QCM technique successfully measured interactions between engineered NPs and target receptors.
• Oriented, grafted nanoparticle constructs showed strong recognition of target receptors, even at low graft densities.
• Randomly adsorbed ligands on NP surfaces resulted in no measurable interaction with target receptors.
• The study efficiently evaluated the effects of ligand graft density, receptor immobilization density, and linker length on interaction outcomes.

Conclusions:

• The QCM technique provides a rapid and effective method for evaluating bionanoparticle-receptor interactions.
• The orientation and grafting density of ligands on nanoparticles significantly impact their recognition by target receptors.
• Ex situ measurement of NP-receptor interactions early in the development process is crucial for rational bionanoparticle design.